{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:08:25Z","timestamp":1761235705224,"version":"3.33.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1136\/ard.2003.011056","type":"journal-article","created":{"date-parts":[[2004,6,11]],"date-time":"2004-06-11T17:48:16Z","timestamp":1086976096000},"page":"862-866","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Autoantibodies against granulocyte\u2212macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome"],"prefix":"10.1016","volume":"63","author":[{"given":"B","family":"Hellmich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Ciaglo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Schatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Coakley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2003.011056_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00005792-199069020-00001","article-title":"The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features and immunogenetic associations","volume":"69","author":"Campion G , Maddison","year":"1990","journal-title":"Medicine"},{"key":"10.1136\/ard.2003.011056_bib2","first-page":"307","article-title":"Humoral and cellular immune mechanisms of neutropenia in patients with Felty\u2019s syndrome","volume":"39","author":"Starkebaum G , Singer","year":"1980","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.2003.011056_bib3","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/1529-0131(200004)43:4<834::AID-ANR14>3.0.CO;2-H","article-title":"CD8+, CD57+ T-cells from healthy elderly subjects suppress neutrophil development in vitro: implications for the neutropenia in Felty\u2019s and large granular lymphocyte syndromes","volume":"43","author":"Coakley G , Iqbal","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.011056_bib4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/art.1780260802","article-title":"Heterogeneity of bone-marrow directed immune mechanisms in the pathogenesis of neutropenia in Felty\u2019s syndrome","volume":"26","author":"Abdou","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.011056_bib5","first-page":"275","article-title":"Inhibition of human bone marrow-granulocyte precursors by serum from patients with Felty\u2019s syndrome","volume":"7","author":"Goldberg L , Bacon","year":"1980","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2003.011056_bib6","first-page":"183","article-title":"Polymorphonuclear leukocyte inclusions and impaired bacterial killing in patients with Felty\u2019s syndrome","volume":"88","author":"Gupta R , LaForce","year":"1976","journal-title":"J Lab Clin Med"},{"key":"10.1136\/ard.2003.011056_bib7","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1002\/art.10497","article-title":"Autoantibodies against granulocyte colony-stimulating factor in Felty\u2019s syndrome and neutropenic systemic lupus erythematosus","volume":"46","author":"Hellmich B , Csernok","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.011056_bib8","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1182\/blood.V89.5.1471","article-title":"The structural and functional basis of cytokine receptor activation: lessons from the common beta subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 receptors","volume":"89","author":"Bagley","year":"1997","journal-title":"Blood"},{"key":"10.1136\/ard.2003.011056_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1359-6101(00)00019-8","article-title":"Specificity in cytokine signal transduction: lessons learned from the IL-3\/IL-5\/GM-CSF receptor family","volume":"12","author":"Geijsen N , Koenderman","year":"2001","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1136\/ard.2003.011056_bib10","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood.V84.12.4078.bloodjournal84124078","article-title":"Induction of anti-recombinant human granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) antibodies and clinical effects in non-immunocompromised patients","volume":"84","author":"Ragnhammar P , Friesen","year":"1994","journal-title":"Blood"},{"key":"10.1136\/ard.2003.011056_bib11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1046\/j.1365-2567.1999.00806.x","article-title":"Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease","volume":"97","author":"Meager","year":"1999","journal-title":"Immunology"},{"key":"10.1136\/ard.2003.011056_bib12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.190.6.875","article-title":"Idiopathic pulmonary aveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte\/macrophage colony-stimulating factor","volume":"190","author":"Kitamura T , Tanaka","year":"1999","journal-title":"J Exp Med"},{"key":"10.1136\/ard.2003.011056_bib13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJMoa011931","article-title":"Pure red-cell aplasi and antierythropoietin antibodies in patients treated with recombinant reythropoietin","volume":"346","author":"Casadevall N , Nataf","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2003.011056_bib14","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1002\/art.1780401216","article-title":"Autoantibodies to human recombinant erythropoietin in patients with systemic lupus erythematosus","volume":"40","author":"Tzioufas A , Kokori","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.011056_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2003.011056_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/rheumatology\/39.4.393","article-title":"Major histocompatility complex haplotypic associations in Felty\u2019s syndrome and large granular lymphocyte syndrome are secondary to allelic association with HLA-DRB1*0401","volume":"39","author":"Coakley G , Brooks","year":"2000","journal-title":"Rheumatology"},{"key":"10.1136\/ard.2003.011056_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02678219","article-title":"Measurement of cytokine antibodies. Test development","volume":"10","author":"Svenson M , Herbrink","year":"1997","journal-title":"Biotherapy"},{"key":"10.1136\/ard.2003.011056_bib18","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1182\/blood.V91.6.2054","article-title":"Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations","volume":"91","author":"Svenson M , Hansen","year":"1998","journal-title":"Blood"},{"key":"10.1136\/ard.2003.011056_bib19","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF02678552","article-title":"Natural and therapeutically induced antibodies to cytokines","volume":"10","author":"Revoltella","year":"1998","journal-title":"Biotherapy"},{"key":"10.1136\/ard.2003.011056_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/10428199709058597","article-title":"Natural and therapy-induced anti-GM-CSF and anti-G-CSF antibodies in human serum","volume":"26","author":"Revoltella R , Laricchia-Robbio","year":"1997","journal-title":"Leukemia Lymphoma"},{"key":"10.1136\/ard.2003.011056_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0002-9343(02)01161-0","article-title":"Low Fc-gamma receptor III and high granulocyte colony-stimulating factor serum levels correlate with risk of infection in neutropenia due to Felty\u2019s syndrome or systemic lupus erythematosus","volume":"113","author":"Hellmich B , Csernok","year":"2002","journal-title":"Am J Med"},{"key":"10.1136\/ard.2003.011056_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF02171759","article-title":"Levels of human serum granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor under pathological conditions","volume":"4","author":"Omori F , Okamura","year":"1992","journal-title":"Biotherapy"},{"key":"10.1136\/ard.2003.011056_bib23","first-page":"648","article-title":"Neutralizing antibodies during treatment of homologous nonglycosylated IL-3 in rhesus monkeys","volume":"8","author":"van Gils F , Westerman","year":"1994","journal-title":"Leukemia"},{"key":"10.1136\/ard.2003.011056_bib24","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4049\/jimmunol.152.2.935","article-title":"IL-6-anti-IL-6 autoantibody complexes with IL-6 activity in sera from some patients with systemic sclerosis","volume":"152","author":"Suzuki H , Takemura","year":"1994","journal-title":"J Immunol"},{"key":"10.1136\/ard.2003.011056_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF02678215","article-title":"Natural antibodies to interferon-gamma","volume":"10","author":"Caruso A , Turano","year":"1997","journal-title":"Biotherapy"},{"key":"10.1136\/ard.2003.011056_bib26","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4049\/jimmunol.144.2.685","article-title":"Natural antibodies to IFN-gamma in man and their increase during viral infection","volume":"144","author":"Caruso A , Bonfanti","year":"1990","journal-title":"J Immunol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672418538X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672418538X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2003.011056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:45:10Z","timestamp":1737438310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672418538X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["S000349672418538X"],"URL":"https:\/\/doi.org\/10.1136\/ard.2003.011056","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies against granulocyte\u2212macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2003.011056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Copyright 2004 by Annals of the Rheumatic Diseases. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}